We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$7.6M
Cap. Flow
-$111K
Cap. Flow %
-0.11%
Top 10 Hldgs %
45.07%
Holding
63
New
2
Increased
19
Reduced
34
Closed
2

Top Buys

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$1.86M
2
GIMO
Gigamon Inc.
GIMO
+$1.18M
3
CVLT icon
Commault Systems
CVLT
+$778K
4
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$354K
5
ENZ
Enzo Biochem, Inc.
ENZ
+$216K

Top Sells

Rank Stock Value
1
IL
IntraLinks Holdings Inc.
IL
+$2.05M
2
ARRY
Array Biopharma Inc
ARRY
+$1.03M
3
ATRC icon
AtriCure
ATRC
+$1.02M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$204K
5
NXTM
NxStage Medical Inc.
NXTM
+$152K

Sector Composition

Rank Sector Weight
1 Healthcare 46.3%
2 Technology 37.9%
3 Industrials 3.2%
4 Financials 2.85%
5 Miscellaneous 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCLR
1
DELISTED
Oclaro Inc.
OCLR
$8.53M 8.34%
868,636
+4,100
+0.5% +$38.5K
XENT
2
DELISTED
Intersect ENT, Inc
XENT
$6.06M 5.92%
353,251
-4,544
-1% -$63.6K
TLGT
3
DELISTED
Teligent, Inc
TLGT
$5.25M 5.14%
67,286
+2,671
+4% +$192K
FNSR
4
DELISTED
Finisar Corp
FNSR
$4.91M 4.8%
179,725
-1,380
-0.8% -$42.3K
AKRX
5
DELISTED
Akorn Inc
AKRX
$4.59M 4.49%
190,793
+85,307
+81% +$1.86M
NEO icon
6
NeoGenomics
NEO
$2.39B
$3.9M 3.82%
494,882
+10,100
+2% +$82.3K
OMCL icon
7
Omnicell
OMCL
$1.52B
$3.6M 3.52%
88,617
-1,230
-1% -$45.3K
SRGA
8
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.27M 3.2%
27,282
+3,400
+14% +$354K
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
$3.16M 3.09%
117,779
-5,488
-4% -$152K
IDTI
10
DELISTED
Integrated Device Technology I
IDTI
$2.82M 2.76%
119,277
-1,879
-2% -$46.1K
GIMO
11
DELISTED
Gigamon Inc.
GIMO
$2.77M 2.7%
77,812
+33,126
+74% +$1.18M
CVLT icon
12
Commault Systems
CVLT
$5.82B
$2.74M 2.68%
53,999
+15,251
+39% +$778K
SWKS icon
13
Skyworks Solutions
SWKS
$10.1B
$2.72M 2.66%
27,776
-374
-1% -$34.1K
LGND icon
14
Ligand Pharmaceuticals
LGND
$5.67B
$2.49M 2.44%
37,773
-354
-0.9% -$23.3K
CALD
15
DELISTED
Callidus Software, Inc.
CALD
$2.41M 2.35%
112,856
+330
+0.3% +$6.34K
EGHT icon
16
8x8 Inc
EGHT
$290M
$2.37M 2.31%
155,100
-1,420
-0.9% -$21.5K
ATRC icon
17
AtriCure
ATRC
$2.51B
$2.27M 2.22%
118,814
-58,495
-33% -$1.02M
QRVO icon
18
Qorvo
QRVO
$8.49B
$2.27M 2.22%
33,165
-379
-1% -$24.4K
KTWO
19
DELISTED
K2M Group Holdings, Inc
KTWO
$2.13M 2.08%
103,889
-6,836
-6% -$140K
ENZ
20
DELISTED
Enzo Biochem, Inc.
ENZ
$2.03M 1.99%
242,640
+30,666
+14% +$216K
PODD icon
21
Insulet
PODD
$9.95B
$2M 1.95%
46,291
-3,267
-7% -$140K
MXL icon
22
MaxLinear
MXL
$5.75B
$1.87M 1.82%
66,550
+1,611
+2% +$41.3K
SPSC icon
23
SPS Commerce
SPSC
$3.03B
$1.55M 1.51%
52,878
+234
+0.4% +$7.19K
SUPN icon
24
Supernus Pharmaceuticals
SUPN
$2.57B
$1.46M 1.42%
46,555
+566
+1% +$15.2K
CYBR
25
DELISTED
CyberArk
CYBR
$1.46M 1.42%
28,616
-235
-0.8% -$12K
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Kopp Investment Advisors held 63 positions worth $102M, up 8% from $94.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Kopp Investment Advisors's Q1 2017 filing shows 2 new, 19 increased, 34 reduced and 2 closed positions. Its largest new stake was Entellus Medical, Inc. Common Stock: 11,819 shares worth $163K. The largest sale was IntraLinks Holdings Inc., an estimated $2.05M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

  • Kopp Investment Advisors's largest Q1 2017 buy was Entellus Medical, Inc. Common Stock: 11,819 shares worth $163K.
  • Kopp Investment Advisors added most to Akorn Inc in Q1 2017, an estimated $1.86M increase.
  • Kopp Investment Advisors's biggest Q1 2017 reduction was Array Biopharma Inc, cutting an estimated $1.03M.
  • Kopp Investment Advisors fully exited IntraLinks Holdings Inc. in Q1 2017, selling an estimated $2.05M.
  • Kopp Investment Advisors's ten largest holdings make up 45% of its $102M portfolio in Q1 2017.
  • Kopp Investment Advisors opened 2 new positions and closed 2 in Q1 2017.
  • Kopp Investment Advisors's portfolio value rose 8% quarter-over-quarter to $102M.

Based on Kopp Investment Advisors's 13F filing for Q1 2017, filed 15 May 2017.